Adenosine induces intrinsic apoptosis via the PI3K/Akt/mTOR signaling pathway in human pharyngeal squamous carcinoma FaDu cells

• Published in: Oncology letters Vol. 15; no. 5; pp. 6489 - 6496
• Main Authors: Choi, Mi Suk, Moon, Sung-Min, Lee, Seul Ah, Park, Bo-Ram, Kim, Jae-Sung, Kim, Do Kyung, Kim, Yong Hwan, Kim, Chun Sung
• Format: Journal Article
• Language: English
• Published: Greece Spandidos Publications 01.05.2018; Spandidos Publications UK Ltd; D.A. Spandidos
• Subjects: Adenosine; Apoptosis; Care and treatment; Cell growth; Cellular signal transduction; Development and progression; Genetic aspects; Health aspects; Kinases; Oncology; Pharyngeal cancer; Squamous cell carcinoma; Studies; Throat cancer; United States > US; adenosine; mTOR; mitochondrial intrinsic apoptotic pathway; Akt; FaDu human pharyngeal squamous carcinoma cells; PI3K
• ISSN: 1792-1074; 1792-1082
• DOI: 10.3892/ol.2018.8089

Adenosine has been identified to occur abundantly intra-and extracellularly, and to exert diverse biological functions, including the suppression of cell proliferation and the induction of apoptosis. Adenosine has been reported to induce apoptosis in several cancer cell lines; however, to the best of our knowledge, the effect of adenosine on head and neck cancer cells has not been investigated. Therefore, the purpose of the present study was to evaluate whether adenosine exerts any anticancer effect via induction of apoptosis in human pharyngeal squamous carcinoma FaDu cells. An MTT assay demonstrated that adenosine-treated FaDu cells inhibited a dose-dependent rate of cell growth, whereas human oral keratinocytes cells were unaffected by adenosine treatment. In addition, A and A adenosine receptor mRNA was detected in FaDu cells by reverse transcription-polymerase chain reaction, and adenosine-induced FaDu cell death was significantly suppressed by treatment with ATL-444, an antagonist of these receptors. Furthermore, adenosine-induced cell growth inhibition was exerted via apoptosis, as confirmed by the analysis of DNA fragmentation, Hoechst nuclear staining and flow cytometry with Annexin V-fluorescein isothiocyanate and propidium iodide staining. Adenosine was also demonstrated to induce an increase in Bcl-associated X expression, a decrease in B-cell lymphoma 2 expression, the release of cytochrome c from mitochondria, and the activation of caspase-3, -9 and poly(ADP-ribose) polymerase in FaDu cells. Finally, phosphoinositide 3-kinase (PI3K), RAC serine/threonine-protein kinase (Akt) and mechanistic target of rapamycin (mTOR) phosphorylation was found to be significantly inhibited in adenosine-treated FaDu cells, as was phosphorylation of the mTOR downregulators, S6 kinase β1, eukaryotic translation initiation factor 4E-binding protein 1, and eukaryotic translation initiation factor 4 γ1. Taken together, these results indicate that adenosine induces apoptosis via the mitochondrial intrinsic pathway, and activates caspase-3 and -9 activity via the PI3K/Akt/mTOR signaling pathway.